View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
  2. Company News
September 7, 2018updated 06 Sep 2018 4:02pm

Deals this week: Body Vision Medical, Attune Medical, Miracor Medical

Medical devices and software services provider Body Vision Medical has raised $8.5m through a financing round led by the company’s chairman Zohar Gilon.

Medical devices and software services provider Body Vision Medical has raised $8.5m through a financing round led by the company’s chairman Zohar Gilon.

Free Report
img

What is driving M&A activity in the MedTech space?

The COVID-19 pandemic has left an indelible mark on the MedTech landscape. Changes in how healthcare is delivered, and new treatment modalities, are creating opportunities and challenges for both new and traditional players. As companies sought out opportunities during the pandemic-driven downturn, the number and value of mergers and acquisition deals in the MedTech space increased. Companies worked to reposition themselves in the newly aligned healthcare world, but with further economic turmoil expected: will these trends be repeated? And what tech areas should firms be looking to expand their capabilities into? GlobalData’s report, “Themes driving M&A activity in the Medical Devices Sector, Q1 2022,” draws upon GlobalData’s extensive MedTech deals databases, highlighting major trends and hot themes in M&A activity. This report will assist you in:
  • Understanding value and volume trends in M&A from Q1 2018 to Q1 2022
  • Understanding regional trends in M&A activity
  • Understanding which medical device sectors are leading M&A activity, and which are lagging
  • Understanding the leading tech trends in Q1 2022 M&A activity
  • Knowing the key deals that occurred during Q1 2022
Download the full report to understand what to expect and how to align your business for success.
by GlobalData
Enter your details here to receive your free Report.

The company plans to use the funds towards the commercialisation of its LungVisionsystem in the US and towards the expansion of its product pipeline.

The FDA-approved LungVisionsystem is an imaging device used in conjunction with standard bronchoscopes for real-time diagnosis.

Attune Medical has closed series C financing by raising funds of more than $15.5m.

Funds will be used towards the expansion of the company’s technology into clinical applications such as prevention of hypothermia during operating room procedures and to support the global adoption of its oesophageal temperature management device, EnsoETM.

Based in the US, Attune Medical is a medical device company involved in the development of temperature management devices.

Miracor Medical SA (Miracor Medical) has raised series D financing of €30m ($34.8m) from Ming Capital, an investor based in China.

“AIT Therapeutics Inc has sold 177,000 unregistered shares of its common stock priced at $4.50 a share to US-based investment firm Lincoln Park Capital Fund LLC.”

The funding round also saw the participation of new investors, including Belgian investment firm Quest for Growth and existing investors Ming Capital, SFPI, and Meusinvest.

The company plans to use the funds to support clinical development and for the commercialisation of the PiCSO® Impulse System.

PiCSO® is a coronary sinus occlusion system, which uses a balloon catheter inserted into the coronary sinus. It is designed to reduce infarct size in patients suffering from acute myocardial infarct.

Based in the US, Miracor Medical is a medical device company that provides innovative solutions for the treatment of severe cardiac diseases.

AIT Therapeutics Inc has sold 177,000 unregistered shares of its common stock priced at $4.50 a share to US-based investment firm Lincoln Park Capital Fund LLC (LPC).

The company plans to sell the balance of $20m-worth shares over a 36-month period to LPC.

AIT plans to use the funds towards the ongoing development of its ventilator-compatible NO Generator and Delivery System and to carry out pivotal studies in bronchiolitis and lung infections.

Based in the US, AIT Therapeutics is a clinical-stage medical device company that uses nitric oxide (NO) to treat respiratory and other diseases.

Related Companies

Free Report
img

What is driving M&A activity in the MedTech space?

The COVID-19 pandemic has left an indelible mark on the MedTech landscape. Changes in how healthcare is delivered, and new treatment modalities, are creating opportunities and challenges for both new and traditional players. As companies sought out opportunities during the pandemic-driven downturn, the number and value of mergers and acquisition deals in the MedTech space increased. Companies worked to reposition themselves in the newly aligned healthcare world, but with further economic turmoil expected: will these trends be repeated? And what tech areas should firms be looking to expand their capabilities into? GlobalData’s report, “Themes driving M&A activity in the Medical Devices Sector, Q1 2022,” draws upon GlobalData’s extensive MedTech deals databases, highlighting major trends and hot themes in M&A activity. This report will assist you in:
  • Understanding value and volume trends in M&A from Q1 2018 to Q1 2022
  • Understanding regional trends in M&A activity
  • Understanding which medical device sectors are leading M&A activity, and which are lagging
  • Understanding the leading tech trends in Q1 2022 M&A activity
  • Knowing the key deals that occurred during Q1 2022
Download the full report to understand what to expect and how to align your business for success.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network